Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1976 Jun;3(3 Suppl 2):395–400. doi: 10.1111/j.1365-2125.1976.tb03732.x

Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control.

R H Mindham
PMCID: PMC1428830  PMID: 9965

Abstract

I have tried to bring out some of the important methodological problems found in examining the effectiveness of drugs used in the control of druginduced parkinsonism by referring mainly to studies in which I have taken part. I hope I have shown that the whole topic is far less well understood than is often assumed. The main points may be summarized as follows: there is doubt as to whether many of the drugs used in controlling drug-induced parkinsonism are really effective; the results of many studies are conflicting; many studies contain serious flaws in design; methods for assessing extrapyramidal signs are not well developed; we are ignorant of the way in which drug-induced extrapyramidal signs change spontaneously. There is a clear need for further research in this area to improve techniques of assessment, to provide basic information on drug-induced syndromes, and to rigorously examine the efficacy of the drugs used in controlling them.

Full text

PDF
395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYD F. J., Jr A survey of drug-induced extrapyramidal reactions. JAMA. 1961 Mar 25;175:1054–1060. doi: 10.1001/jama.1961.03040120016004. [DOI] [PubMed] [Google Scholar]
  2. Angus J. W., Simpson G. M. Handwriting changes and response to drugs--a controlled study. Acta Psychiatr Scand Suppl. 1970;212:28–37. doi: 10.1111/j.1600-0447.1970.tb02068.x. [DOI] [PubMed] [Google Scholar]
  3. BRUMLIK J., CANTER G., DELATORRE R., MIER M., PETROVICK M., BOSHES B. A CRITICAL ANALYSIS OF THE EFFECTS OF TRIHEXYPHENIDYL (ARTANE) ON THE COMPONENTS OF THE PARKINSONIAN SYNDROME. J Nerv Ment Dis. 1964 May;138:424–431. doi: 10.1097/00005053-196405000-00002. [DOI] [PubMed] [Google Scholar]
  4. CAHAN R. B., PARRISH D. D. Reversibility of drug-induced parkinsonism. Am J Psychiatry. 1960 May;116:1022–1023. doi: 10.1176/ajp.116.11.1022. [DOI] [PubMed] [Google Scholar]
  5. Corrodi H., Fuxe K., Ungerstedt U. Evidence for a new type of dopamine receptor stimulating agent. J Pharm Pharmacol. 1971 Dec;23(12):989–991. doi: 10.1111/j.2042-7158.1971.tb09916.x. [DOI] [PubMed] [Google Scholar]
  6. Ekdawi M. Y., Fowke R. A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism. Br J Psychiatry. 1966 Jun;112(487):633–636. doi: 10.1192/bjp.112.487.633. [DOI] [PubMed] [Google Scholar]
  7. Godwin-Austen R. B., Tomlinson E. B., Frears C. C., Kok H. W. Effects of L-dopa in Parkinson's disease. Lancet. 1969 Jul 26;2(7613):165–168. doi: 10.1016/s0140-6736(69)91417-2. [DOI] [PubMed] [Google Scholar]
  8. Horne D. J. Sensorimotor control in Parkinsonism. J Neurol Neurosurg Psychiatry. 1973 Oct;36(5):742–746. doi: 10.1136/jnnp.36.5.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MANDEL W., OLIVER W. A. Withdrawal of maintenance antiparkinson drug in the phenothiazine-induced extrapyramidal reaction. Am J Psychiatry. 1961 Oct;118:350–351. doi: 10.1176/ajp.118.4.350. [DOI] [PubMed] [Google Scholar]
  10. Meier M. J., Martin W. E. Measurement of behavioural changes in patients on L-dopa. Lancet. 1970 Feb 14;1(7642):352–353. doi: 10.1016/s0140-6736(70)90723-3. [DOI] [PubMed] [Google Scholar]
  11. Mindham R. H., Gaind R., Anstee B. H., Rimmer L. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism. Psychol Med. 1972 Nov;2(4):406–413. doi: 10.1017/s0033291700045220. [DOI] [PubMed] [Google Scholar]
  12. STRANG R. R. KEMADRIN IN THE TREATMENT OF PARKINSONISM: A DOUBLE BLIND AND ONE-YEAR FOLLOW-UP STUDY. Curr Med Drugs. 1965 Apr;5(8):27–32. [PubMed] [Google Scholar]
  13. Simpson G. M., Angus J. W. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;212:11–19. doi: 10.1111/j.1600-0447.1970.tb02066.x. [DOI] [PubMed] [Google Scholar]
  14. Simpson G. M. Controlled studies of antiparkinsonism agents in the treatment of drug-induced extrapyramidal sympttoms. Acta Psychiatr Scand Suppl. 1970;212:44–51. doi: 10.1111/j.1600-0447.1970.tb02070.x. [DOI] [PubMed] [Google Scholar]
  15. ZUNG W. W. A SELF-RATING DEPRESSION SCALE. Arch Gen Psychiatry. 1965 Jan;12:63–70. doi: 10.1001/archpsyc.1965.01720310065008. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES